chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (left arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     The patient's past medical history included Skin melanoma removed in 2020 and Laser therapy.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (left arm). At the time of the report, MYALGIA (left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products was provided by the reporter. No treatment information was provided by the reporter.   This case was linked to MOD-2021-294294 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chest discomfort, Pain, Pleurisy, Pyrexia
Clinical narrative: low grade fever of 100 degrees; scarring; pulling at her left chest; lung pleurisy (inflammation of lung lining); excruciating pain; This spontaneous case was reported by a consumer and describes the occurrence of SCAR (scarring), CHEST DISCOMFORT (pulling at her left chest), PLEURISY (lung pleurisy (inflammation of lung lining)), PAIN (excruciating pain) and PYREXIA (low grade fever of 100 degrees) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PYREXIA (low grade fever of 100 degrees). In 2021, the patient experienced SCAR (scarring), CHEST DISCOMFORT (pulling at her left chest), PLEURISY (lung pleurisy (inflammation of lung lining)) and PAIN (excruciating pain). The patient was treated with PARACETAMOL (TYLENOL) in February 2021 at a dose of 1 dosage form and MELOXICAM in February 2021 at a dose of 1 dosage form. At the time of the report, SCAR (scarring) and CHEST DISCOMFORT (pulling at her left chest) had not resolved and PLEURISY (lung pleurisy (inflammation of lung lining)), PAIN (excruciating pain) and PYREXIA (low grade fever of 100 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 100 (High) low grade fever of 100 degrees.         No Concomitant product use was provided by the reporter.   Lab data included CT with contrast and chest x ray result was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Scar
Clinical narrative: low grade fever of 100 degrees; scarring; pulling at her left chest; lung pleurisy (inflammation of lung lining); excruciating pain; This spontaneous case was reported by a consumer and describes the occurrence of SCAR (scarring), CHEST DISCOMFORT (pulling at her left chest), PLEURISY (lung pleurisy (inflammation of lung lining)), PAIN (excruciating pain) and PYREXIA (low grade fever of 100 degrees) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PYREXIA (low grade fever of 100 degrees). In 2021, the patient experienced SCAR (scarring), CHEST DISCOMFORT (pulling at her left chest), PLEURISY (lung pleurisy (inflammation of lung lining)) and PAIN (excruciating pain). The patient was treated with PARACETAMOL (TYLENOL) in February 2021 at a dose of 1 dosage form and MELOXICAM in February 2021 at a dose of 1 dosage form. At the time of the report, SCAR (scarring) and CHEST DISCOMFORT (pulling at her left chest) had not resolved and PLEURISY (lung pleurisy (inflammation of lung lining)), PAIN (excruciating pain) and PYREXIA (low grade fever of 100 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 100 (High) low grade fever of 100 degrees.         No Concomitant product use was provided by the reporter.   Lab data included CT with contrast and chest x ray result was unknown.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Fatigue, Illness, Vaccination site pain
Clinical narrative: felt ill, sick; had an increase in the  soreness of the injection site/increasing soreness after injection; extremely fatigued all day; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS, VACCINATION SITE PAIN, and FATIGUE in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037a21b and 044a21a) for COVID-19 vaccination.     Previously administered products included for an unreported indication: OCREVUS on 30-Dec-2020. Concurrent medical conditions included Multiple sclerosis (Patient is on Ocrevus infusion) and Immunosuppression. Concomitant products included OCREVUS from 30-Jun-2021 to an unknown date for Multiple sclerosis, BUPROPION, ADDERALL, FISH OIL, OMEGA 3, and BACLOFEN for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS, VACCINATION SITE PAIN, and FATIGUE. The patient was treated with BENADRYL at an unspecified dose and frequency. At the time of the report, ILLNESS, VACCINATION SITE PAIN, and FATIGUE had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement high, Increase in blood pressure.   Patient received 3 doses of the Moderna COVID19 vaccine. Patient stated that he had no side effect following the first two doses.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Has not received the second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received the second dose yet) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received the second dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not received the second dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  The treatment information was  not provided.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea, Fatigue, Headache
Clinical narrative: Achylegs; weak; sore arm; Lightheaded; Short of breath; Rash at the injection site; Headache/head hurt; tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Achylegs), ASTHENIA (weak), PAIN IN EXTREMITY (sore arm), DIZZINESS (Lightheaded) and DYSPNEA (Short of breath) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Achylegs), ASTHENIA (weak), PAIN IN EXTREMITY (sore arm), DIZZINESS (Lightheaded), DYSPNEA (Short of breath), VACCINATION SITE RASH (Rash at the injection site), HEADACHE (Headache/head hurt) and FATIGUE (tired). At the time of the report, PAIN IN EXTREMITY (Achylegs), ASTHENIA (weak), PAIN IN EXTREMITY (sore arm), DIZZINESS (Lightheaded), DYSPNEA (Short of breath), VACCINATION SITE RASH (Rash at the injection site), HEADACHE (Headache/head hurt) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported. Treatment medication were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash
Clinical narrative: Achylegs; weak; sore arm; Lightheaded; Short of breath; Rash at the injection site; Headache/head hurt; tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Achylegs), ASTHENIA (weak), PAIN IN EXTREMITY (sore arm), DIZZINESS (Lightheaded) and DYSPNEA (Short of breath) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Achylegs), ASTHENIA (weak), PAIN IN EXTREMITY (sore arm), DIZZINESS (Lightheaded), DYSPNEA (Short of breath), VACCINATION SITE RASH (Rash at the injection site), HEADACHE (Headache/head hurt) and FATIGUE (tired). At the time of the report, PAIN IN EXTREMITY (Achylegs), ASTHENIA (weak), PAIN IN EXTREMITY (sore arm), DIZZINESS (Lightheaded), DYSPNEA (Short of breath), VACCINATION SITE RASH (Rash at the injection site), HEADACHE (Headache/head hurt) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported. Treatment medication were not reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest pain, Dyspnoea, Headache
Clinical narrative: shortness of breath/lungs not filling with air; low energy; chest aches; headache; sore arm/ achy; tested positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/lungs not filling with air), ASTHENIA (low energy), CHEST PAIN (chest aches), HEADACHE (headache) and MYALGIA (sore arm/ achy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath/lungs not filling with air), ASTHENIA (low energy), CHEST PAIN (chest aches), HEADACHE (headache), MYALGIA (sore arm/ achy) and COVID-19 (tested positive for covid-19). At the time of the report, DYSPNOEA (shortness of breath/lungs not filling with air), ASTHENIA (low energy), CHEST PAIN (chest aches), HEADACHE (headache), MYALGIA (sore arm/ achy) and COVID-19 (tested positive for covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       She was treated with an infusion since she is older and high risk on 12Aug2021.  No Treatment information  were reported
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: shortness of breath/lungs not filling with air; low energy; chest aches; headache; sore arm/ achy; tested positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/lungs not filling with air), ASTHENIA (low energy), CHEST PAIN (chest aches), HEADACHE (headache) and MYALGIA (sore arm/ achy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath/lungs not filling with air), ASTHENIA (low energy), CHEST PAIN (chest aches), HEADACHE (headache), MYALGIA (sore arm/ achy) and COVID-19 (tested positive for covid-19). At the time of the report, DYSPNOEA (shortness of breath/lungs not filling with air), ASTHENIA (low energy), CHEST PAIN (chest aches), HEADACHE (headache), MYALGIA (sore arm/ achy) and COVID-19 (tested positive for covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       She was treated with an infusion since she is older and high risk on 12Aug2021.  No Treatment information  were reported
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Inappropriate schedule of product administration, Peripheral swelling
Clinical narrative: Swollen Left Arm after the third shot; Red Left Arm after the third shot; Booster dose was taken outside the window period; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen Left Arm after the third shot), ERYTHEMA (Red Left Arm after the third shot) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was taken outside the window period) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination.     Concomitant products included IMMUNOGLOBULIN HUMAN NORMAL (HIZENTRA) for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Aug-2021, the patient experienced PERIPHERAL SWELLING (Swollen Left Arm after the third shot), ERYTHEMA (Red Left Arm after the third shot) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was taken outside the window period). On 17-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was taken outside the window period) had resolved. On 19-Aug-2021, PERIPHERAL SWELLING (Swollen Left Arm after the third shot) and ERYTHEMA (Red Left Arm after the third shot) had resolved.            Treatment information was not provided.   Patient had no side effects after first and second doses of vaccine.  She stated to have a colonoscopy done(outine and not related to vaccine).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Lot of problems after second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Lot of problems after second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Lot of problems after second dose). At the time of the report, VACCINATION COMPLICATION (Lot of problems after second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product information was provided.  Treatment information was not provided.  Reporter thought not getting second dose because reporter concerned about it being unapproved and heard a lot of things about the second dose
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: Problems with her hands; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Problems with her hands) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Problems with her hands). At the time of the report, LIMB DISCOMFORT (Problems with her hands) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. No Treatment Information was provided by the reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, COVID-19, Chills, Facial pain, Headache
Clinical narrative: Patient experienced covid like symptoms after receiving 1st dose; cold; face ache; Stomach ache; Next day, she started with headaches; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), FACIAL PAIN (face ache), ABDOMINAL PAIN UPPER (Stomach ache), HEADACHE (Next day, she started with headaches) and MYALGIA (body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medication history information was provided.  Concomitant products included TERBINAFINE for Fungal infection, ESCITALOPRAM for an unknown indication.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Aug-2021, the patient experienced NASOPHARYNGITIS (cold), FACIAL PAIN (face ache), ABDOMINAL PAIN UPPER (Stomach ache), HEADACHE (Next day, she started with headaches), MYALGIA (body aches) and CHILLS (chills). On an unknown date, the patient experienced COVID-19 (Patient experienced covid like symptoms after receiving 1st dose). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (cold), FACIAL PAIN (face ache), ABDOMINAL PAIN UPPER (Stomach ache), HEADACHE (Next day, she started with headaches), MYALGIA (body aches), CHILLS (chills) and COVID-19 (Patient experienced covid like symptoms after receiving 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also include supplements.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasopharyngitis
Clinical narrative: Patient experienced covid like symptoms after receiving 1st dose; cold; face ache; Stomach ache; Next day, she started with headaches; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), FACIAL PAIN (face ache), ABDOMINAL PAIN UPPER (Stomach ache), HEADACHE (Next day, she started with headaches) and MYALGIA (body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medication history information was provided.  Concomitant products included TERBINAFINE for Fungal infection, ESCITALOPRAM for an unknown indication.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Aug-2021, the patient experienced NASOPHARYNGITIS (cold), FACIAL PAIN (face ache), ABDOMINAL PAIN UPPER (Stomach ache), HEADACHE (Next day, she started with headaches), MYALGIA (body aches) and CHILLS (chills). On an unknown date, the patient experienced COVID-19 (Patient experienced covid like symptoms after receiving 1st dose). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (cold), FACIAL PAIN (face ache), ABDOMINAL PAIN UPPER (Stomach ache), HEADACHE (Next day, she started with headaches), MYALGIA (body aches), CHILLS (chills) and COVID-19 (Patient experienced covid like symptoms after receiving 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also include supplements.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Lymphadenopathy, Vaccination site pain
Clinical narrative: Aux lymph nodes under left armpit are very swollen; Sore at injection site; Slept all day; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept all day), LYMPHADENOPATHY (Aux lymph nodes under left armpit are very swollen) and VACCINATION SITE PAIN (Sore at injection site) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052C21A, 025L20A and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised (Immunocompromised with lupus but in remission) and Insomnia. Concomitant products included ESZOPICLONE (LUNESTA) for Insomnia, HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]) and GABAPENTIN for an unknown indication.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021, the patient experienced HYPERSOMNIA (Slept all day) and VACCINATION SITE PAIN (Sore at injection site). On 23-Aug-2021, the patient experienced LYMPHADENOPATHY (Aux lymph nodes under left armpit are very swollen). On 23-Aug-2021, HYPERSOMNIA (Slept all day) had resolved. At the time of the report, LYMPHADENOPATHY (Aux lymph nodes under left armpit are very swollen) and VACCINATION SITE PAIN (Sore at injection site) outcome was unknown.            Concomitant medication including Multivitamin/calcium was reported.  No treatment information was provided.   This case was linked to MOD-2021-294485, MOD-2021-294519 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: The shot is very painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (The shot is very painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (The shot is very painful). At the time of the report, VACCINATION SITE PAIN (The shot is very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was provided by the reporter.   No treatment medications were reported.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Feeling abnormal, Heart rate increased, Hypoaesthesia, Myalgia
Clinical narrative: feeling numb; tingling sensation  in her left arm and  all the way to the fingers, which ended up in her left leg, and  to the toes of that leg.; felt pain for the  whole week which would not go away; she feels fogginess; tenderness; discomfort; sore arm, - left arm was sore and started hurting a lot.; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), DISCOMFORT (discomfort), HYPOAESTHESIA (feeling numb), PARAESTHESIA (tingling sensation  in her left arm and  all the way to the fingers, which ended up in her left leg, and  to the toes of that leg.) and PAIN (felt pain for the  whole week which would not go away) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A-1) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), PARACETAMOL (TYLENOL), Migraine medications and INHALER for an unknown indication.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced DISCOMFORT (discomfort) and MYALGIA (sore arm, - left arm was sore and started hurting a lot.). On 16-Aug-2021, the patient experienced TENDERNESS (tenderness). On an unknown date, the patient experienced HYPOAESTHESIA (feeling numb), PARAESTHESIA (tingling sensation  in her left arm and  all the way to the fingers, which ended up in her left leg, and  to the toes of that leg.), PAIN (felt pain for the  whole week which would not go away) and FEELING ABNORMAL (she feels fogginess). The patient was treated with PREDNISONE at a dose of 10 milligram. At the time of the report, TENDERNESS (tenderness), DISCOMFORT (discomfort), HYPOAESTHESIA (feeling numb), PARAESTHESIA (tingling sensation  in her left arm and  all the way to the fingers, which ended up in her left leg, and  to the toes of that leg.), PAIN (felt pain for the  whole week which would not go away), FEELING ABNORMAL (she feels fogginess) and MYALGIA (sore arm, - left arm was sore and started hurting a lot.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate increased: increased (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paraesthesia, Tenderness
Clinical narrative: feeling numb; tingling sensation  in her left arm and  all the way to the fingers, which ended up in her left leg, and  to the toes of that leg.; felt pain for the  whole week which would not go away; she feels fogginess; tenderness; discomfort; sore arm, - left arm was sore and started hurting a lot.; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), DISCOMFORT (discomfort), HYPOAESTHESIA (feeling numb), PARAESTHESIA (tingling sensation  in her left arm and  all the way to the fingers, which ended up in her left leg, and  to the toes of that leg.) and PAIN (felt pain for the  whole week which would not go away) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A-1) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), PARACETAMOL (TYLENOL), Migraine medications and INHALER for an unknown indication.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced DISCOMFORT (discomfort) and MYALGIA (sore arm, - left arm was sore and started hurting a lot.). On 16-Aug-2021, the patient experienced TENDERNESS (tenderness). On an unknown date, the patient experienced HYPOAESTHESIA (feeling numb), PARAESTHESIA (tingling sensation  in her left arm and  all the way to the fingers, which ended up in her left leg, and  to the toes of that leg.), PAIN (felt pain for the  whole week which would not go away) and FEELING ABNORMAL (she feels fogginess). The patient was treated with PREDNISONE at a dose of 10 milligram. At the time of the report, TENDERNESS (tenderness), DISCOMFORT (discomfort), HYPOAESTHESIA (feeling numb), PARAESTHESIA (tingling sensation  in her left arm and  all the way to the fingers, which ended up in her left leg, and  to the toes of that leg.), PAIN (felt pain for the  whole week which would not go away), FEELING ABNORMAL (she feels fogginess) and MYALGIA (sore arm, - left arm was sore and started hurting a lot.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate increased: increased (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site mass
Clinical narrative: he had a bump that was about size of a golf ball,It went away completely after about 3 days. Now 4 days later, it came back. It's not as hard as before. The bump is at the injection site; He had a left sore arm.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (He had a left sore arm.) and VACCINATION SITE MASS (he had a bump that was about size of a golf ball,It went away completely after about 3 days. Now 4 days later, it came back. It's not as hard as before. The bump is at the injection site) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Aug-2021, the patient experienced PAIN IN EXTREMITY (He had a left sore arm.). On 15-Aug-2021, the patient experienced VACCINATION SITE MASS (he had a bump that was about size of a golf ball,It went away completely after about 3 days. Now 4 days later, it came back. It's not as hard as before. The bump is at the injection site). At the time of the report, PAIN IN EXTREMITY (He had a left sore arm.) outcome was unknown and VACCINATION SITE MASS (he had a bump that was about size of a golf ball,It went away completely after about 3 days. Now 4 days later, it came back. It's not as hard as before. The bump is at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided. No treatment information was mentioned.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 4 patients were administered with this expired vaccine/ we have administered a vaccine beyond the expiration date by 24 hours what is the recommendation; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 patients were administered with this expired vaccine/ we have administered a vaccine beyond the expiration date by 24 hours what is the recommendation) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 patients were administered with this expired vaccine/ we have administered a vaccine beyond the expiration date by 24 hours what is the recommendation). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 patients were administered with this expired vaccine/ we have administered a vaccine beyond the expiration date by 24 hours what is the recommendation) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Fatigue after 1st and 2nd dose; Headaches after 1st and 2nd dose; Soreness at injection site after 1st and 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue after 1st and 2nd dose), HEADACHE (Headaches after 1st and 2nd dose) and VACCINATION SITE PAIN (Soreness at injection site after 1st and 2nd dose) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History was provided.  Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S), GABAPENTIN, ESZOPICLONE (LUNESTA), MULTIVITAMIN [VITAMINS NOS] and CALCIUM for an unknown indication.    On 22-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue after 1st and 2nd dose), HEADACHE (Headaches after 1st and 2nd dose) and VACCINATION SITE PAIN (Soreness at injection site after 1st and 2nd dose). At the time of the report, FATIGUE (Fatigue after 1st and 2nd dose), HEADACHE (Headaches after 1st and 2nd dose) and VACCINATION SITE PAIN (Soreness at injection site after 1st and 2nd dose) outcome was unknown.            No Treatment Medications were provided.   This case was linked to MOD-2021-294441, MOD-2021-294519 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Legs and calves were hurting real bad; Soreness in his legs and calves; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Legs and calves were hurting real bad) and MYALGIA (Soreness in his legs and calves) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21N) for COVID-19 vaccination.     Concurrent medical conditions included Pain, Blood pressure and Cholesterol. Concomitant products included LISINOPRIL for Blood pressure, PRAVASTATIN for Cholesterol, TEMAZEPAM for an unknown indication.    On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Legs and calves were hurting real bad) and MYALGIA (Soreness in his legs and calves). At the time of the report, PAIN IN EXTREMITY (Legs and calves were hurting real bad) and MYALGIA (Soreness in his legs and calves) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Additional concomitant medication include pain medication.   This case was linked to MOD-2021-294323 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19
Clinical narrative: she was symptomatic and tested positive for covid19; This spontaneous case was reported by an other health care professional and describes the occurrence of SUSPECTED COVID-19 (she was symptomatic and tested positive for covid19) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Aug-2021, the patient experienced SUSPECTED COVID-19 (she was symptomatic and tested positive for covid19). At the time of the report, SUSPECTED COVID-19 (she was symptomatic and tested positive for covid19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Aug-2021, SARS-CoV-2 test: positive (Positive) tested positive for covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was provided by the reporter.   No Treatment information was provided.  Patient reports she has since tested negative. Patient is due for her second dose of the vaccine 27Friday2021.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Could not sleep at night because of pain; Itching in the afternoon; Swelling last night; Pain in the area of injection/if she touches it there is no pain, but only the sensation; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Could not sleep at night because of pain), VACCINATION SITE PRURITUS (Itching in the afternoon), VACCINATION SITE SWELLING (Swelling last night) and VACCINATION SITE PAIN (Pain in the area of injection/if she touches it there is no pain, but only the sensation) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. N/A, N/A and N/A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic lymphocytic leukemia and Cataracts.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021, the patient experienced INSOMNIA (Could not sleep at night because of pain), VACCINATION SITE PRURITUS (Itching in the afternoon), VACCINATION SITE SWELLING (Swelling last night) and VACCINATION SITE PAIN (Pain in the area of injection/if she touches it there is no pain, but only the sensation). On 23-Aug-2021, VACCINATION SITE PRURITUS (Itching in the afternoon), VACCINATION SITE SWELLING (Swelling last night) and VACCINATION SITE PAIN (Pain in the area of injection/if she touches it there is no pain, but only the sensation) had resolved. At the time of the report, INSOMNIA (Could not sleep at night because of pain) outcome was unknown.            Concomitant medications were not provided.  Treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects after they got the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects after they got the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects after they got the vaccine). At the time of the report, VACCINATION COMPLICATION (Side effects after they got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.   Treatment information was not provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Myalgia, Pain
Clinical narrative: Back pain; pain moved to all of their long bones and muscles/been beaten with a bat; myalgia/been beaten with a bat; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), PAIN (pain moved to all of their long bones and muscles/been beaten with a bat) and MYALGIA (myalgia/been beaten with a bat) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Cough (believes they had COVID-19 because they suffered having a bad cough back) from 24-Jan-2020 to 15-Feb-2020. Concurrent medical conditions included Migraine. Concomitant products included FENTANYL, MORPHINE and TOPIRAMATE (TOPAMAX) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back pain), PAIN (pain moved to all of their long bones and muscles/been beaten with a bat) and MYALGIA (myalgia/been beaten with a bat). At the time of the report, BACK PAIN (Back pain), PAIN (pain moved to all of their long bones and muscles/been beaten with a bat) and MYALGIA (myalgia/been beaten with a bat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.  The patient reports about 2 hours after getting the first and second dose they experienced severe myalgia.  The patient described it as "been beaten with a bat,patient explained these symptoms lasted through the first night, was gone the next day, then the pain came back the following day, and finally the next day it all went away.   This case was linked to MOD-2021-294576, MOD-2021-294577 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Asthenia, Body temperature, Cough
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness) and ABDOMINAL PAIN UPPER (Epigastric pain) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness), ABDOMINAL PAIN UPPER (Epigastric pain), PYREXIA (fever (100°F average)), ARTHRALGIA (joint pain), MYALGIA (muscle aches), HEADACHE (headache (occipital region)), FATIGUE (fatigue) and PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose/got the 1st dose back in January). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and OMEPRAZOLE at an unspecified dose and frequency. At the time of the report, THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness), ABDOMINAL PAIN UPPER (Epigastric pain), PYREXIA (fever (100°F average)), ARTHRALGIA (joint pain), MYALGIA (muscle aches), HEADACHE (headache (occipital region)) and FATIGUE (fatigue) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose/got the 1st dose back in January) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: increased (High) 100 degree Fahrenheit average. On an unknown date, Heart rate: increased (High) 115 bpm average heart rate. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient mentioned taking birth control as concomitants. The patient went to the hospital several times and received medication there.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Heart rate, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness) and ABDOMINAL PAIN UPPER (Epigastric pain) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness), ABDOMINAL PAIN UPPER (Epigastric pain), PYREXIA (fever (100°F average)), ARTHRALGIA (joint pain), MYALGIA (muscle aches), HEADACHE (headache (occipital region)), FATIGUE (fatigue) and PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose/got the 1st dose back in January). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and OMEPRAZOLE at an unspecified dose and frequency. At the time of the report, THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness), ABDOMINAL PAIN UPPER (Epigastric pain), PYREXIA (fever (100°F average)), ARTHRALGIA (joint pain), MYALGIA (muscle aches), HEADACHE (headache (occipital region)) and FATIGUE (fatigue) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose/got the 1st dose back in January) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: increased (High) 100 degree Fahrenheit average. On an unknown date, Heart rate: increased (High) 115 bpm average heart rate. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient mentioned taking birth control as concomitants. The patient went to the hospital several times and received medication there.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia, Thyroiditis
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness) and ABDOMINAL PAIN UPPER (Epigastric pain) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness), ABDOMINAL PAIN UPPER (Epigastric pain), PYREXIA (fever (100°F average)), ARTHRALGIA (joint pain), MYALGIA (muscle aches), HEADACHE (headache (occipital region)), FATIGUE (fatigue) and PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose/got the 1st dose back in January). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and OMEPRAZOLE at an unspecified dose and frequency. At the time of the report, THYROIDITIS (thyroiditis), COUGH (cough), DYSPNOEA (shortness of breath), ASTHENIA (weakness), ABDOMINAL PAIN UPPER (Epigastric pain), PYREXIA (fever (100°F average)), ARTHRALGIA (joint pain), MYALGIA (muscle aches), HEADACHE (headache (occipital region)) and FATIGUE (fatigue) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose/got the 1st dose back in January) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: increased (High) 100 degree Fahrenheit average. On an unknown date, Heart rate: increased (High) 115 bpm average heart rate. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient mentioned taking birth control as concomitants. The patient went to the hospital several times and received medication there.